wb 4101 has been researched along with Diabetes Mellitus, Adult-Onset in 1 studies
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine : A benzodioxine that is 2,3-dihydro-1,4-benzodioxine bearing a [(2',6'-dimethoxyphenoxy)ethylamino]methyl group at position 2. An alpha1A-adrenergic selective antagonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artasensi, A | 1 |
| Angeli, A | 1 |
| Lammi, C | 1 |
| Bollati, C | 1 |
| Gervasoni, S | 1 |
| Baron, G | 1 |
| Matucci, R | 1 |
| Supuran, CT | 1 |
| Vistoli, G | 1 |
| Fumagalli, L | 1 |
1 other study available for wb 4101 and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Discovery of a Potent and Highly Selective Dipeptidyl Peptidase IV and Carbonic Anhydrase Inhibitor as "Antidiabesity" Agents Based on Repurposing and Morphing of WB-4101.
Topics: Adrenergic Agents; Caco-2 Cells; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Diabetes Mellit | 2022 |